Keppra XR (levetiracetam) extended-release tablets have been made available by UCB in a 750mg dosage strength. This dosage strength will allow healthcare providers to simplify treatment plans by reducing the number of tablets patients take each day.

Keppra XR is indicated as an adjunct in partial onset seizures in patients ≥16 years of age and is already available in a 500mg dosage strength.

For more information call (866) 822-0068 or visit